{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T07:23:20Z","timestamp":1772781800570,"version":"3.50.1"},"reference-count":55,"publisher":"American Society of Hematology","issue":"3","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2006,2,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Bullous pemphigoid (BP) is an autoimmune disease associated with autoantibodies directed against the hemidesmosomal antigens anti-BP230 and anti-B180. Neonatal mice injected with rabbit anti-mouse BP180 (mBP10) IgG develop a BP-like disease. Complement, immune complexes, mast cells, and neutrophils play a key role in subepidermal blistering in this animal model. In this study we investigated the role of \u03b22 integrins in experimental BP. Wild-type (WT) mice pretreated with neutralizing antibody against CD11a (LFA-1), CD11b (Mac-1), CD11a plus CD11b, or CD18 alone failed to develop BP when injected with pathogenic anti-mBP180 IgG. This was associated with a significant reduction in neutrophil accumulation in neutralizing antibody-treated mice. Mac-1-deficient (Mac-1 knockout [KO]) mice were resistant to experimental BP despite normal complement deposition and mast cell and neutrophil degranulation. Neutrophil infiltration in Mac-1 KO mice was severely impaired at 24 hours. However, more neutrophils accumulated in the skin of Mac-1 KO mice compared with WT mice at early time points (2-4 hours), which was associated with an increase in their survival as determined by apoptosis markers. These data suggest that \u03b22 integrins play differential roles in experimental BP: LFA-1 is required for neutrophil recruitment, while Mac-1 mediates late neutrophil accumulation and apoptosis of infiltrating neutrophils.<\/jats:p>","DOI":"10.1182\/blood-2005-08-3123","type":"journal-article","created":{"date-parts":[[2005,10,19]],"date-time":"2005-10-19T03:39:03Z","timestamp":1129693143000},"page":"1063-1069","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":29,"title":["Differential roles for \u03b22 integrins in experimental autoimmune bullous pemphigoid"],"prefix":"10.1182","volume":"107","author":[{"given":"Zhi","family":"Liu","sequence":"first","affiliation":[{"name":"From the Departments of Dermatology, Microbiology, and Immunology, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill; and the Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minglang","family":"Zhao","sequence":"additional","affiliation":[{"name":"From the Departments of Dermatology, Microbiology, and Immunology, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill; and the Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ning","family":"Li","sequence":"additional","affiliation":[{"name":"From the Departments of Dermatology, Microbiology, and Immunology, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill; and the Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis A.","family":"Diaz","sequence":"additional","affiliation":[{"name":"From the Departments of Dermatology, Microbiology, and Immunology, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill; and the Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tanya N.","family":"Mayadas","sequence":"additional","affiliation":[{"name":"From the Departments of Dermatology, Microbiology, and Immunology, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill; and the Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"234","reference":[{"key":"2019111711180855900_REF1","doi-asserted-by":"crossref","unstructured":"Lever WF. Pemphigus. Medicine. 1953;32: 1-123.","DOI":"10.1097\/00005792-195302000-00001"},{"key":"2019111711180855900_REF2","doi-asserted-by":"crossref","unstructured":"Jordon RE, Beutner EH, Witebsky E, Blumental G, Hale WC, Lever WF. Basement zone antibodies in bullous pemphigoid. JAMA. 1967;200: 751-758.","DOI":"10.1001\/jama.1967.03120220053008"},{"key":"2019111711180855900_","doi-asserted-by":"crossref","unstructured":"Jordon RE. Complement activation in pemphigus and bullous pemphigoid. J Invest Derm. 1976;67: 366-371.","DOI":"10.1111\/1523-1747.ep12514708"},{"key":"2019111711180855900_","doi-asserted-by":"crossref","unstructured":"Katz SI, Hertz KC, Yaoita H. Herpes gestationis. Immunopathology and characterization of the HG factor. J Clin Invest. 1976;57: 1434-1441.","DOI":"10.1172\/JCI108413"},{"key":"2019111711180855900_REF5","doi-asserted-by":"crossref","unstructured":"Stanley JR, Hawley-Nelson P, Yuspa SH, Shevach EM, Katz SI. Characterization of bullous pemphigoid antigen: a unique basement membrane protein of stratified epithelia. Cell. 1981;24: 897-903.","DOI":"10.1016\/0092-8674(81)90115-X"},{"key":"2019111711180855900_","doi-asserted-by":"crossref","unstructured":"Mutasim DF, Takahashi Y, Labib RS, Anhalt GJ, Patel HP, Diaz LA. A pool of bullous pemphigoid antigen(s) is intracellular and associated with the basal cell cytoskeleton-hemidesmosome complex. J Invest Dermatol. 1985;84: 47-53.","DOI":"10.1111\/1523-1747.ep12274684"},{"key":"2019111711180855900_REF7","doi-asserted-by":"crossref","unstructured":"Labib RS, Anhalt GJ, Patel HP, Mutasim DF, Diaz LA. Molecular heterogeneity of bullous pemphigoid antigens as detected by immunoblotting. J Immunol. 1986;136: 1231-1235.","DOI":"10.4049\/jimmunol.136.4.1231"},{"key":"2019111711180855900_REF8","doi-asserted-by":"crossref","unstructured":"Tanaka T, Parry DAD, Klaus-Kovtun V, Steinert PM, Stanley JR. Comparison of molecularly cloned bullous pemphigoid antigen to desmoplakin I confirms that they define a new family of cell adhesion junction plaque proteins. J Biol Chem. 1991;266: 12555-12559.","DOI":"10.1016\/S0021-9258(18)98934-9"},{"key":"2019111711180855900_REF9","doi-asserted-by":"crossref","unstructured":"Sawamura D, Li K, Chu M-L, Uitto J. Human bullous pemphigoid antigen (BPAG1): amino acid sequences deduced from cloned cDNAs predict biologically important peptide segments and protein domains. J Biol Chem. 1991;266: 17784-17790.","DOI":"10.1016\/S0021-9258(18)55195-4"},{"key":"2019111711180855900_REF10","doi-asserted-by":"crossref","unstructured":"Diaz LA, Ratrie H III, Saunders WS, et al. Isolation of a human epidermal cDNA corresponding to the 180-kD autoantigen recognized by bullous pemphigoid and herpes gestationis sera: immunolocalization of this protein to the hemidesmosome. J Clin Invest. 1990;86: 1088-1094.","DOI":"10.1172\/JCI114812"},{"key":"2019111711180855900_","doi-asserted-by":"crossref","unstructured":"Giudice GJ, Squiquera HL, Elias PM, Diaz LA. Identification of two collagen domains within the bullous pemphigoid autoantigen, BP180. J Clin Invest. 1991;87: 734-738.","DOI":"10.1172\/JCI115054"},{"key":"2019111711180855900_","doi-asserted-by":"crossref","unstructured":"Giudice GJ, Emery DJ, Diaz LA. Cloning and primary structural analysis of the bullous pemphigoid autoantigen, BP-180. J Invest Dermatol. 1992;99: 243-250.","DOI":"10.1111\/1523-1747.ep12616580"},{"key":"2019111711180855900_REF13","doi-asserted-by":"crossref","unstructured":"Hopkinson SB, Riddelle KS, Jones JRC. Cytoplasmic domain of the 180-kD bullous pemphigoid antigen, a hemidesmosomal component: molecular and cell biologic characterization. J Invest Dermatol. 1992;99: 264-270.","DOI":"10.1111\/1523-1747.ep12616615"},{"key":"2019111711180855900_","doi-asserted-by":"crossref","unstructured":"Bedane C, McMillan JR, Balding SD, et al. Bullous pemphigoid and cicatricial pemphigoid auto-antibodies react with ultrastructurally separable epitopes on the BP180 ectodomain: evidence that BP180 spans the lamina lucida. J Invest Derm. 1997;108: 901-907.","DOI":"10.1111\/1523-1747.ep12292701"},{"key":"2019111711180855900_","doi-asserted-by":"crossref","unstructured":"Hirako Y, Usukura J, Nishizawa Y, Owaribe K. Demonstration of the molecular shape of BP180, a 180-kDa bullous pemphigoid antigen and its potential for trimer formation. J Biol Chem. 1996;271: 13739-13745.","DOI":"10.1074\/jbc.271.23.13739"},{"key":"2019111711180855900_REF16","doi-asserted-by":"crossref","unstructured":"Balding SD, Diaz LA, Giudice GJ. A recombinant form of the human BP180 ectodomain forms a collagen-like homotrimeric complex. Biochemistry. 1997;36: 8821-8830.","DOI":"10.1021\/bi970675n"},{"key":"2019111711180855900_REF17","doi-asserted-by":"crossref","unstructured":"Giudice GJ, Emery DJ, Zelickson BD, Anhalt GJ, Liu Z, Diaz LA. Bullous pemphigoid and herpes gestationis autoantibodies recognize a common non-collagenous site on the BP180 ectodomain. J Immunol. 1993;151: 5742-5750.","DOI":"10.1016\/0923-1811(93)90940-Q"},{"key":"2019111711180855900_REF18","doi-asserted-by":"crossref","unstructured":"Zillikens D, Rose PM, Balding SD, et al. Tight clustering of extracellular BP180 epitopes recognized by bullous pemphigoid autoantibodies. J Invest Dermatol. 1997;109: 573-579.","DOI":"10.1111\/1523-1747.ep12337492"},{"key":"2019111711180855900_REF19","doi-asserted-by":"crossref","unstructured":"Liu Z, Diaz LA, Troy JL, et al. A passive transfer model of the organ-specific autoimmune disease, bullous pemphigoid, using antibodies generated against the hemidesmosomal antigen, BP180. J Clin Invest. 1993;92: 2480-2488.","DOI":"10.1172\/JCI116856"},{"key":"2019111711180855900_REF20","doi-asserted-by":"crossref","unstructured":"Liu Z, Giudice GJ, Swartz SJ, et al. The role of complement in experimental bullous pemphigoid. J Clin Invest. 1995;95: 1539-1544.","DOI":"10.1172\/JCI117826"},{"key":"2019111711180855900_REF21","doi-asserted-by":"crossref","unstructured":"Chen R, Ning G, Zhao ML, et al. Mast cells play a key role on neutrophil recruitment in experimental bullous pemphigoid. J Clin Invest. 2001;108: 1151-1158.","DOI":"10.1172\/JCI11494"},{"key":"2019111711180855900_REF22","doi-asserted-by":"crossref","unstructured":"Liu Z, Giudice GJ, Zhou X, et al. A major role for neutrophils in experimental bullous pemphigoid. J Clin Invest. 1997;100: 1256-1263.","DOI":"10.1172\/JCI119639"},{"key":"2019111711180855900_REF23","doi-asserted-by":"crossref","unstructured":"Liu Z, Shipley JM, Vu TH, et al. Gelatinase B-deficient mice are resistant to experimental BP. J Exp Med. 1998;188: 475-482.","DOI":"10.1084\/jem.188.3.475"},{"key":"2019111711180855900_REF24","doi-asserted-by":"crossref","unstructured":"Liu Z, Shapiro SD, Zhou X, et al. A critical role for neutrophil elastase in experimental bullous pemphigoid. J Clin Invest. 2000;105: 113-123.","DOI":"10.1172\/JCI3693"},{"key":"2019111711180855900_REF25","doi-asserted-by":"crossref","unstructured":"Liu Z, Zhou X, Shapiro SD, et al. The serpin \u03b11-proteinase inhibitor is a critical substrate for gelatinase B\/MMP-9 in vivo. Cell. 2000;102: 647-655.","DOI":"10.1016\/S0092-8674(00)00087-8"},{"key":"2019111711180855900_REF26","doi-asserted-by":"crossref","unstructured":"Springer TA. Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell. 1994;76: 301-314.","DOI":"10.1016\/0092-8674(94)90337-9"},{"key":"2019111711180855900_REF27","doi-asserted-by":"crossref","unstructured":"Harris ES, McIntyre TM, Prescott SM, Zimmerman GA. The leukocyte integrins. J Biol Chem. 2000;275: 23409-23412.","DOI":"10.1074\/jbc.R000004200"},{"key":"2019111711180855900_REF28","doi-asserted-by":"crossref","unstructured":"Larson RS, Springer TA. Structure and function of leukocyte integrins. Immunol Rev. 1990;114: 181-217.","DOI":"10.1111\/j.1600-065X.1990.tb00565.x"},{"key":"2019111711180855900_REF29","doi-asserted-by":"crossref","unstructured":"Hynes RO. Integrins: bidirectional, allosteric signaling machines. Cell. 2002;110: 673-687.","DOI":"10.1016\/S0092-8674(02)00971-6"},{"key":"2019111711180855900_REF30","doi-asserted-by":"crossref","unstructured":"Coxon A, Rieu P, Barkalow FJ, et al. A novel role for the \u03b22 integrin CD11b\/CD18 in neutrophil apoptosis: a homeostatic mechanism in inflammation. Immunity. 1996;5: 653-666.","DOI":"10.1016\/S1074-7613(00)80278-2"},{"key":"2019111711180855900_REF31","doi-asserted-by":"crossref","unstructured":"Ross GD. Regulation of adhesion versus cytotoxic functions of the Mac-1\/CR3\/\u03b1M\u03b22-integrin glycoprotein. Crit Rev Immunol. 2000;20: 197-222.","DOI":"10.1615\/CritRevImmunol.v20.i3.20"},{"key":"2019111711180855900_REF32","doi-asserted-by":"crossref","unstructured":"Li K, Tamai K, Tan EML, Uitto J. Cloning of type XVII collagen: complementary and genomic DNA sequences of mouse 180-Kilodalton bullous pemphigoid antigen (BPAG2) predict an interrupted collagenous domain, a transmembrane segment, and unusual features in the 5\u2032-end of the gene and the 3\u2032-untranslated region of the mRNA. J Biol Chem. 1993;268: 8825-8834.","DOI":"10.1016\/S0021-9258(18)52948-3"},{"key":"2019111711180855900_REF33","doi-asserted-by":"crossref","unstructured":"Liu Z, Diaz LA, Haas AL, Giudice GJ. cDNA cloning of a novel human ubiquitin carrier protein: an antigenic domain specifically recognized by endemic pemphigus foliaceus autoantibodies is encoded in a secondary reading frame of this human epidermal transcript. J Biol Chem. 1992;267: 15829-15835.","DOI":"10.1016\/S0021-9258(19)49610-5"},{"key":"2019111711180855900_REF34","doi-asserted-by":"crossref","unstructured":"Bradley PP, Priebat DA, Christensen RD, Rothstein G. Measurement of cutaneous inflammation: estimation of neutrophil content with an enzyme marker. J Invest Dermatol. 1982;78: 206-209.","DOI":"10.1111\/1523-1747.ep12506462"},{"key":"2019111711180855900_REF35","doi-asserted-by":"crossref","unstructured":"Wershil BK, Wang Z, Jordon JR, Galli SJ. Recruitment of neutrophils during IgE-dependent cutaneous late phase responses in the mouse is mast cell dependent: partial inhibition of the reaction with antiserum against tumor necrosis factor-alpha. J Clin Invest. 1991;87: 446-453.","DOI":"10.1172\/JCI115016"},{"key":"2019111711180855900_REF36","unstructured":"Metcalf JA, Gallin JI, Nauseef WM, Root RK. Laboratory Manual of Neutrophil Function. New York, NY: Raven Press; 1985: 2-10."},{"key":"2019111711180855900_REF37","doi-asserted-by":"crossref","unstructured":"Liu Z, Li N, Diaz LA, Shipley M, Senior RM, Werb Z. Synergy between a plasminogen cascade and MMP-9 in autoimmune disease. J Clin Invest. 2005;115: 879-887.","DOI":"10.1172\/JCI23977"},{"key":"2019111711180855900_REF38","doi-asserted-by":"crossref","unstructured":"Bin Z, Hirahashi J, Cullere X, Mayadas TN. Elucidation of molecular events leading to neutrophil apoptosis following phagocytosis. J Biol Chem. 2003;278: 28443-28454.","DOI":"10.1074\/jbc.M210727200"},{"key":"2019111711180855900_REF39","doi-asserted-by":"crossref","unstructured":"Lu H, Smith CW, Perrard J, et al. LFA-1 is sufficient in mediating neutrophil emigration in Mac-1-deficient mice. J Clin Invest. 1997;99: 1340-1350.","DOI":"10.1172\/JCI119293"},{"key":"2019111711180855900_REF40","doi-asserted-by":"crossref","unstructured":"Ding ZM, Babensee JE, Simon SI, et al. Relative contribution of LFA-1 and Mac-1 to neutrophil adhesion and migration. J Immunol. 1999;163: 5029-5038.","DOI":"10.4049\/jimmunol.163.9.5029"},{"key":"2019111711180855900_REF41","doi-asserted-by":"crossref","unstructured":"Kevil CG, Hicks MJ, He X, et al. Loss of LFA-1, but not Mac-1, protects MRL\/MpJ-Fas(lpr) mice from autoimmune disease. Am J Pathol. 2004;165: 609-616.","DOI":"10.1016\/S0002-9440(10)63325-1"},{"key":"2019111711180855900_REF42","doi-asserted-by":"crossref","unstructured":"Watts GM, Beurskens FJ, Martin-Padura I, et al. Manifestations of inflammatory arthritis are critically dependent on LFA-1. J Immunol. 2005;174: 3668-3675.","DOI":"10.4049\/jimmunol.174.6.3668"},{"key":"2019111711180855900_REF43","doi-asserted-by":"crossref","unstructured":"Dunne JL, Ballantyne CM, Beaudet AL, Ley K. Control of leukocyte rolling velocity in TNF-alpha-induced inflammation by LFA-1 and Mac-1. Blood. 2002;99: 336-341.","DOI":"10.1182\/blood.V99.1.336"},{"key":"2019111711180855900_REF44","doi-asserted-by":"crossref","unstructured":"Hendersona RB, Limb LHK, Tessiera PA, et al. The use of lymphocyte function-associated antigen (LFA)-1-deficient mice to determine the role of LFA-1, Mac-1, and \u03b14 integrin in the inflammatory response of neutrophils. J Exp Med. 2001;194: 219-226.","DOI":"10.1084\/jem.194.2.219"},{"key":"2019111711180855900_REF45","doi-asserted-by":"crossref","unstructured":"Tang T, Rosenkranz A, Assmann KJ, et al. A role for Mac-1 (CDIIb\/CD18) in immune complex-stimulated neutrophil function in vivo: Mac-1 deficiency abrogates sustained Fc receptor-dependent neutrophil adhesion and complement-dependent proteinuria in acute glomerulonephritis. J Exp Med. 1997;186: 1853-1863.","DOI":"10.1084\/jem.186.11.1853"},{"key":"2019111711180855900_REF46","doi-asserted-by":"crossref","unstructured":"Soriano SG, Coxon A, Wang YF, et al. Mice deficient in Mac-1 (CD11b\/CD18) are less susceptible to cerebral ischemia\/reperfusion injury. Stroke. 1999;30: 134-139.","DOI":"10.1161\/01.STR.30.1.134"},{"key":"2019111711180855900_REF47","doi-asserted-by":"crossref","unstructured":"Arumugam TV, Salter JW, Chidlow JH, Ballantyne CM, Kevil CG, Granger DN. Contributions of LFA-1 and Mac-1 to brain injury and microvascular dysfunction induced by transient middle cerebral artery occlusion. Am J Physiol Heart Circ Physiol. 2004;287: H2555-H2560.","DOI":"10.1152\/ajpheart.00588.2004"},{"key":"2019111711180855900_REF48","doi-asserted-by":"crossref","unstructured":"Walzog B, Weinmann P, Jeblonski F, Scharffetter-Kochanek K, Bommert K, Gaehtgens P. A role for \u03b22 integrins (CD11\/CD18) in the regulation of cytokine gene expression of polymorphonuclear neutrophils during the inflammatory response. FASEB J. 1999;13: 1855-1865.","DOI":"10.1096\/fasebj.13.13.1855"},{"key":"2019111711180855900_REF49","doi-asserted-by":"crossref","unstructured":"Kettritz R, Choi M, Rolle S, Wellner M, Luft FC. Integrins and cytokines activate nuclear transcription factor-kappaB in human neutrophils. J Biol Chem. 2004;279: 2657-2665.","DOI":"10.1074\/jbc.M309778200"},{"key":"2019111711180855900_REF50","doi-asserted-by":"crossref","unstructured":"Hentzen ER, Neelamegham S, Kansas GS, et al. Sequential binding of CD11a\/CD18 and CD11b\/CD18 defines neutrophil capture and stable adhesion to intercellular adhesion molecule-1. Blood. 2000;95: 911-220.","DOI":"10.1182\/blood.V95.3.911.003k36_911_920"},{"key":"2019111711180855900_REF51","doi-asserted-by":"crossref","unstructured":"Mayadas TN, Cullere X. Neutrophil \u03b22 integrins: moderators of life or death decisions. Trends Immunol. 2005;26: 388-395.","DOI":"10.1016\/j.it.2005.05.002"},{"key":"2019111711180855900_REF52","doi-asserted-by":"crossref","unstructured":"Morrison LH, Labib RS, Zone JJ, Diaz LA, Anhalt GJ. Herpes gestationis autoantibodies recognize a 180-kD human epidermal antigen. J Clin Invest. 1988;81: 2023-2026.","DOI":"10.1172\/JCI113554"},{"key":"2019111711180855900_","doi-asserted-by":"crossref","unstructured":"Bernard P, Prost C, Durepaire N, Basset-Seguin N, Didierjean L, Saurat JH. The major cicatricial pemphigoid antigen is a 180-kD protein that shows immunologic cross-reactivities with the bullous pemphigoid antigen. J Invest Dermatol. 1992;99: 174-179.","DOI":"10.1111\/1523-1747.ep12616797"},{"key":"2019111711180855900_","doi-asserted-by":"crossref","unstructured":"Tamada Y, Yokochi K, Nitta Y, Toshihiko I, Hara K, Owaribe K. Lichen planus pemphigoides: identification of 180 kD hemidesmosome antigen. J Am Acad Dermatol. 1995;32: 883-887.","DOI":"10.1016\/0190-9622(95)91554-0"},{"key":"2019111711180855900_REF55","doi-asserted-by":"crossref","unstructured":"Zone JJ, Taylor TB, Meyer LJ, Peterson MJ. The 97 kDa linear IgA bullous disease antigen is identical to a portion of the extracellular domain of the 180 kDa bullous pemphigoid antigen, BPAg2. J Invest Dermatol. 1998;110: 207-210.","DOI":"10.1046\/j.1523-1747.1998.00129.x"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/107\/3\/1063\/1281704\/zh800306001063.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/107\/3\/1063\/1281704\/zh800306001063.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,5]],"date-time":"2023-05-05T04:18:11Z","timestamp":1683260291000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/107\/3\/1063\/22170\/Differential-roles-for-%CE%B22-integrins-in"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,2,1]]},"references-count":55,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2006,2,1]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2005-08-3123","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,2,1]]}}}